How does rhinovirus cause the common cold cough?

BMJ Open Respiratory Research

Volumn 3, Issue 1, 2016, Pages

  Atkinson, Samantha K ^a   Sadofsky, Laura R ^a   Morice, Alyn H ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRADYKININ; CADHERIN; CALCITONIN GENE RELATED PEPTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 8; LEUKOTRIENE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MUCIN 5AC; MUSCARINIC RECEPTOR; NERVE GROWTH FACTOR; POLYINOSINIC POLYCYTIDYLIC ACID; PURINERGIC P2X3 RECEPTOR; PURINERGIC RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; TACHYKININ; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 2; VANILLOID RECEPTOR 4;

AIRWAY; ARTICLE; BRONCHOCONSTRICTION; CELL DISRUPTION; CELL JUNCTION; CLINICAL TRIAL (TOPIC); COLD STRESS; COMMON COLD; COUGHING; DISEASE MODEL; EOSINOPHIL; GAP JUNCTION; GENE EXPRESSION; GOBLET CELL; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; METAPLASIA; MICTURITION REFLEX; MUCUS SECRETION; NEUROGENIC INFLAMMATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RHINOVIRUS; RHINOVIRUS INFECTION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; UPPER RESPIRATORY TRACT INFECTION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 84964532491     PISSN: None     EISSN: 20524439     Source Type: Journal    
DOI: 10.1136/bmjresp-2015-000118     Document Type: Article

References (201)

1. Witek TJ, Ramsey DL, Carr AN, et al. The natural history of community-acquired common colds symptoms assessed over 4-years. Rhinology 2015;53:81-8.
2. Eccles R, Loose I, Jawad M, et al. Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection. Pain Med 2003;4:118-24.
3. Curley FJ, Irwin RS, Pratter MR, et al. Cough and the common cold. Am Rev Respir Dis 1988;138:305-11.
4. Reid DD, Williams RE, Hirch A. Colds among office workers an epidemiological study. Lancet 1953;262:1303-6.
5. Braman SS. Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest 2006;129:138S-46S.
6. Irwin RS, Baumann MH, Bolser DC, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 2006;129:1S-23S.
7. Morice AH, Fontana GA, Belvisi MG, et al. ERS guidelines on the assessment of cough. Eur Respir J 2007;29:1256-76.
8. Morice AH. The cough hypersensitivity syndrome: a novel paradigm for understanding cough. Lung 2010;188(Suppl):S87-90.
9. Dicpinigaitis PV, Tibb AS, Ramsey DL, et al. Stability of cough reflex sensitivity during viral upper respiratory tract infection (common cold). Pulm Pharmacol Ther 2014;28:154-7.
10. Dicpinigaitis PV, Bhat R, Rhoton WA, et al. Effect of viral upper respiratory tract infection on the urge-to-cough sensation. Respir Med 2011;105:615-18.
11. O'Connell F, Thomas VE, Studham JM, et al. Capsaicin cough sensitivity increases during upper respiratory infection. Respir Med 1996;90:279-86.
12. McGarvey LPA, Morice AH. Clinical cough and its mechanisms. Respir Physiol Neurobiol 2006;152:363-71.
13. Schroeder K, Fahey T. Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults. BMJ 2002;324:329-31.
14. Eccles R, Morris S, Jawad M. Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharm Ther 1992;17:175-80.
15. Morice AH, McGarvey L, Pavord I, et al. Recommendations for the management of cough in adults. Thorax 2006;61Suppl -24.
16. Morice AH, Kastelik JA, Thompson R. Cough challenge in the assessment of cough reflex. Br J Clin Pharmacol 2001;52:365-75.
17. Laude EA, Higgins KS, Morice AH. A comparative study of the effects of citric acid, capsaicin and resiniferatoxin on the cough challenge in guinea-pig and man. Pulm Pharmacol 1993;6: 171-5.
18. Collier JG, Fuller RW. Capsaicin inhalation in man and the effects of sodium cromoglycate. Br J Pharmacol 1984;81:113-17.
19. Benemei S, Patacchini R, Trevisani M, et al. TRP channels. Curr Opin Pharmacol 2015;22:18-23.
20. Birrell MA, Belvisi MG, Grace M, et al. TRPA1 agonists evoke coughing in guinea pig and human volunteers. Am J Respir Crit Care Med 2009;180:1042-7.
21. Khalid S, Murdoch R, Newlands A, et al. Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial. J Allergy Clin Immunol 2014;134:56-62.
22. Morice AH. Developing antitussives the clinician's pipeline—what do we need? J Thorac Dis 2014;6:S735-8.
23. Grace MS, Dubuis E, Birrell MA, et al. Pre-clinical studies in cough research: role of Transient Receptor Potential (TRP) channels. Pulm Pharmacol Ther 2013;26:498-507.
24. Kamei J, Takahashi Y, Yoshikawa Y, et al. Involvement of P2X receptor subtypes in ATP-induced enhancement of the cough reflex sensitivity. Eur J Pharmacol 2005;528:158-61.
25. Tomassini JE, Graham D, DeWitt CM, et al. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1989;86:4907-11.
26. Ye XM, Zhong NS, Liu CL, et al. Cough reflex sensitivity is increased in guinea pigs with parainfluenza virus infection. Exp Lung Res 2011;37:186-94.
27. Papadopoulos NG, Johnston SL. Rhinoviruses as pathogens of the lower respiratory tract. Can Respir J 2000;7:409-14.
28. Stockl J, Vetr H, Majdic O, et al. Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. J Clin Invest 1999;104:957-65.
29. Proud D, Reynolds CJ, Lacapra S, et al. Nasal provocation with Bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 1988;137:613-16.
30. Bandell M, Story GM, Hwang SW, et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004;41:849-57.
31. Carr MJ, Kollarik M, Meeker SN, et al. A role for TRPV1 in bradykinin-induced excitation of vagal airway afferent nerve terminals. J Pharmacol Exp Ther 2003;304:1275-9.
32. Fox AJ, Lalloo UG, Belvisi MG, et al. Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat Med 1996;2:814-17.
33. Chuang HH, Prescott ED, Kong H, et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5) P2-mediated inhibition. Nature 2001;411:957-62.
34. Baumgarten CR, Lehmkuhl B, Henning R, et al. Bradykinin and other inflammatory mediators in BAL-fluid from patients with active pulmonary inflammation. Agents Actions Suppl 1992;38(Pt 3):475-81.
35. Yeo WW, Foster G, Ramsay LE. Prevalence of persistent cough during long-term enalapril treatment: controlled study versus nifedipine. Q J Med 1991;80:763-70.
36. Grace M, Birrell MA, Dubuis E, et al. Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin. Thorax 2012;67:891-900.
37. Joos GF, Germonpre PR, Kips JC, et al. Sensory neuropeptides and the human lower airways: present state and future directions. Eur Respir J 1994;7:1161-71.
38. Lundberg JM, Brodin E, Hua X, et al. Vascular permeability changes and smooth muscle contraction in relation to capsaicin-sensitive substance P afferents in the guinea-pig. Acta Physiol Scand 1984;120:217-27.
39. Rogers DF, Aursudkij B, Barnes PJ. Effects of tachykinins on mucus secretion in human bronchi in vitro. Eur J Pharmacol 1989;174:283-6.
40. Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 1998;30:5-11.
41. Numao T, Agrawal DK. Neuropeptides modulate human eosinophil chemotaxis. J Immunol 1992;149:3309-15.
42. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988;241:1218-21.
43. Morice AH, Lowry R, Brown MJ, et al. Angiotensin-converting enzyme and the cough reflex. Lancet 1987;2:1116-18.
44. Jacoby DB. Pathophysiology of airway viral infections. Pulm Pharmacol Ther 2004;17:333-6.
45. Bae Y-J, Moon KA, Kim T-B, et al. The role of nitrosative stress in the pathogenesis of unexplained chronic cough with cough hypersensitivity. Am J Rhinol Allergy 2012;26:e10-14.
46. Otsuka K, Niimi A, Matsumoto H, et al. Plasma substance P levels in patients with persistent cough. Respiration 2011;82: 431-8.
47. Cho Y, Park S, Lee CK, et al. Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin. J AllergyClin Immunol 2003;112:695-701.
48. Moore KA, Undem BJ, Weinreich D. Antigen inhalation unmasks NK-2 tachykinin receptor-mediated responses in vagal afferents. Am J Respir Crit Care Med 2000;161:232-6.
49. Appelgren A, Appelgren B, Kopp S, et al. Substance P-associated increase of intra-articular temperature and pain threshold in the arthritic TMJ. J Orofac Pain 1998;12:101-7.
50. Evengard B, Nilsson CG, Lindh G, et al. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 1998;78:153-5.
51. El-Hashim AZ, Amine SA. The role of substance P and bradykinin in the cough reflex and bronchoconstriction in guinea-pigs. Eur J Pharmacol 2005;513:125-33.
52. Katsumata U, Sekizawa K, Inoue H, et al. Inhibitory actions of procaterol, a beta-2 stimulant, on substance P-induced cough in normal subjects during upper respiratory tract infection. Tohoku J Exp Med 1989;158:105-6.
53. Bonham AC, Kott KS, Ravi K, et al. Substance P contributes to rapidly adapting receptor responses to pulmonary venous congestion in rabbits. J Physiol 1996;493(Pt 1):229-38.
54. Kichko TI, Reeh PW. TRPV1 controls acid- and heat-induced calcitonin gene-related peptide release and sensitization by bradykinin in the isolated mouse trachea. Eur J Neurosci 2009;29:1896-904.
55. Mak JCW, Barnes PJ. Autoradiographic localization of calcitonin gene-related peptide (CGRP) binding sites in human and guinea pig lung. Peptides 1988;9:957-63.
56. Cadieux A, Monast NP, Pomerleau F, et al. Bronchoprotector properties of calcitonin gene-related peptide in guinea pig and human airways. Effect of pulmonary inflammation. Am J RespirCrit Care Med 1999;159:235-43.
57. Dakhama A, Kanehiro A, Makela MJ, et al. Regulation of airway hyperresponsiveness by calcitonin gene-related peptide in allergen sensitized and challenged mice. Am J Respir Crit Care Med 2002;165:1137-44.
58. Lassen L, Haderslev P, Jacobsen V, et al. CGRP may play a causative role in migraine. Cephalalgia 2002;22:54-61.
59. Hua X-Y, Chen P, Fox A, et al. Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: studies with interleukin-1beta and tumor necrosis factor-alpha. J Neurosci 1996;16:4742-8.
60. Chang AB, Gibson PG, Ardill J, et al. Calcitonin gene-related peptide relates to cough sensitivity in children with chronic cough. Eur Respir J 2007;30:66-72.
61. O'Connell F, Springall DR, Moradoghli-Haftvani A, et al. Abnormal intraepithelial airway nerves in persistent unexplained cough? Am J Respir Crit Care Med 1995;152:2068-75.
62. Dakhama A, Park J-W, Taube C, et al. Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 2005;288:L761-70.
63. Webber SE, Lim JC, Widdicombe JG. The effects of calcitonin gene-related peptide on submucosal gland secretion and epithelial albumin transport in the ferret trachea in vitro. Br J Pharmacol 1991;102:79-84.
64. Hammarstrom S. Leukotrienes. Annu Rev Biochem 1983;52:355-77.
65. Seymour ML, Gilby N, Bardin PG, et al. Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis 2002;185:540-4.
66. Profita M, Di Giorgi R, Sala A, et al. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005;60:1361-9.
67. Takemura M, Niimi A, Matsumoto H, et al. Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma. Respiration 2012;83:308-15.
68. Wang K, Birring SS, Taylor K, et al. Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial. Lancet Respir Med 2014;2:35-43.
69. Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008;38:709-50.
70. Evans CM, Fryer AD, Jacoby DB, et al. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest 1997;100:2254-62.
71. Larsen GL, Fame TM, Renz H, et al. Increased acetylcholine release in tracheas from allergen-exposed IgE-immune mice. Am J Physiol 1994;266:L263-70.
72. Hisamatsu K, Ganbo T, Nakazawa T, et al. Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro. J Allergy Clin Immunol 1990;86:52-63.
73. Pegorier S, Wagner LA, Gleich GJ, et al. Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J Immunol 2006;177:4861-9.
74. Teran LM, Seminario MC, Shute JK, et al. RANTES, macrophage-inhibitory protein 1alpha, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma exacerbations in children. J Infect Dis 1999;179:677-81.
75. Nishio N, Taniguchi W, Sugimura YK, et al. Reactive oxygen species enhance excitatory synaptic transmission in rat spinal dorsal horn neurons by activating TRPA1 and TRPV1 channels. Neuroscience 2013;247:201-12.
76. Andersson DA, Gentry C, Moss S, et al. Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress. J Neurosci 2008;28:2485-94.
77. Mak JC, Barnes PJ. Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. Am Rev Respir Dis 1990;141:1559-68.
78. Gosens R, Zaagsma J, Meurs H, et al. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 2006;7:73.
79. Rogers DF. Motor control of airway goblet cells and glands. Respir Physiol 2001;125:129-44.
80. Fryer AD, Maclagan J. Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 1984;83:973-8.
81. Bowerfind WML, Fryer AD, Jacoby DB. Double-stranded RNA causes airway hyperreactivity and neuronal M2 muscarinic receptor dysfunction. J Appl Physiol 2002;92:1417-22.
82. Jacoby DB, Xiao HQ, Lee NH, et al. Virus- and interferon-induced loss of inhibitory M2 muscarinic receptor function and gene expression in cultured airway parasympathetic neurons. J Clin Invest 1998;102:242-8.
83. Jacoby DB, Yost BL, Kumaravel B, et al. Glucocorticoid treatment increases inhibitory m(2) muscarinic receptor expression and function in the airways. Am J Respir Cell Mol Biol 2001;24:485-91.
84. Lowry R, Wood A, Higenbottam T. The effect of anticholinergic bronchodilator therapy on cough during upper respiratory tract infections. Br J Clin Pharmacol 1994;37:187-91.
85. Puhakka T, Makela MJ, Malmstrom K, et al. The common cold: effects of intranasal fluticasone propionate treatment. J Allergy Clin Immunol 1998;101:726-31.
86. Winther B, Gwaltney JM, Hendley JO. Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am Rev Respir Dis 1990;141:839-45.
87. Monto AS, Gravenstein S, Elliott M, et al. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000;160:3243-7.
88. Rezaee F, Meednu N, Emo JA, et al. Polyinosinic:polycytidylic acid induces protein kinase D-dependent disassembly of apical junctions and barrier dysfunction in airway epithelial cells. J Allergy Clin Immunol 2011;128:1216-2411.
89. Yeo N-K, Jang YJ. Rhinovirus infection-induced alteration of tight junction and adherens junction components in human nasal epithelial cells. Laryngoscope 2010;120:346-52.
90. Sajjan U, Wang Q, Zhao Y, et al. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med 2008;178:1271-81.
91. Reiter B, Kraft R, Gunzel D, et al. TRPV4-mediated regulation of epithelial permeability. FASEBJ 2006;20:1802-12.
92. Yamaya M, Sekizawa K, Masuda T, et al. Oxidants affect permeability and repair of the cultured human tracheal epithelium. Am J Physiol 1995;268:L284-93.
93. Comstock AT, Ganesan S, Chattoraj A, et al. Rhinovirus-induced barrier dysfunction in polarized airway epithelial cells is mediated by NADPH oxidase 1. J Virol 2011;85:6795-808.
94. Kaul P, Biagioli MC, Singh I, et al. Rhinovirus-induced oxidative stress and interleukin-8 elaboration involves p47-phox but is independent of attachment to intercellular adhesion molecule-1 and viral replication. J Infect Dis 2000;181:1885-90.
95. Unger BL, Ganesan S, Comstock AT, et al. Nod-like receptor X-1 is required for rhinovirus-induced barrier dysfunction in airway epithelial cells. J Virol 2014;88:3705-18.
96. Arnoult D, Soares F, Tattoli I, et al. An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. J Cell Sci 2009;122:3161-8.
97. Tattoli I, Carneiro LA, Jehanno M, et al. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kB and JNK pathways by inducing reactive oxygen species production. EMBO Rep 2008;9:293-300.
98. Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005;6:981-8.
99. Meylan E, Curran J, Hofmann K, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005;437:1167-72.
100. Seth RB, Sun L, Ea C-K, et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005;122:669-82.
101. Hewson CA, Jardine A, Edwards MR, et al. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol 2005;79:12273-9.
102. Soyka MB, Wawrzyniak P, Eiwegger T, et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-y and IL-4. J Allergy Clin Immunol 2012;130:1087-9610.
103. Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003;171:6164-72.
104. Biagioli MC, Kaul P, Singh I, et al. The role of oxidative stress in rhinovirus induced elaboration of IL-8 by respiratory epithelial cells. Free Radic Biol Med 1999;26:454-62.
105. Wang JH, Kwon HJ, Jang YJ. Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts. Laryngoscope 2009;119:1834-8.
106. Leigh R, Oyelusi W, Wiehler S, et al. Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J Allergy Clin Immunol 2008;121:1238-454.
107. Psarras S, Volonaki E, Skevaki CL, et al. Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. J Allergy Clin Immunol 2006;117:291-7.
108. Newcomb DC, Sajjan US, Nagarkar DR, et al. Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am J Respir Crit Care Med 2008;177:1111-21.
109. Bossios A, Psarras S, Gourgiotis D, et al. Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells. Respir Res 2005;6:114.
110. Yuta A, Doyle WJ, Gaumond E, et al. Rhinovirus infection induces mucus hypersecretion. Am J Physiol Lung Cell Mol Physiol 1998;274:L1017-23.
111. Phipps RJ, Richardson PS. The effects of irritation at various levels of the airway upon tracheal mucus secretion in the cat. J Physiol 1976;261:563-81.
112. Hewson CA, Haas JJ, Bartlett NW, et al. Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-kB and EGFR pathways. Eur Respir J 2010;36:1425-35.
113. Zhu L, Lee P-K, Lee W-M, et al. Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway. Am J Respir Cell Mol Biol 2009;40:610-19.
114. Inoue D, Yamaya M, Kubo H, et al. Mechanisms of mucin production by rhinovirus infection in cultured human airway epithelial cells. Respir Physiol Neurobiol 2006;154:484-99.
115. Zhu Z, Tang W, Gwaltney JM, et al. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. Am J Physiol 1997;273:L814-24.
116. Zhu Z, Tang W, Ray A, et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest 1996;97:421-30.
117. Casalino-Matsuda SM, Monzón ME, Forteza RM. Epidermal growth factor receptor activation by epidermal growth factor mediates oxidant-induced goblet cell metaplasia in human airway epithelium. Am J Respir Cell Mol Biol 2006;34:581-91.
118. Ishihara H, Shimura S, Satoh M, et al. Muscarinic receptor subtypes in feline tracheal submucosal gland secretion. Am J Physiol 1992;262:L223-8.
119. Ramnarine SI, Haddad EB, Khawaja AM, et al. On muscarinic control of neurogenic mucus secretion in ferret trachea. J Physiol 1996;494(Pt 2):577-86.
120. Iwase N, Sasaki T, Oshiro T, et al. Differential effect of epidermal growth factor on serous and mucous cells in porcine airway submucosal gland. Respir Physiol Neurobiol 2002;132:307-19.
121. Kanno H, Horikawa Y, Hodges RR, et al. Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. AJP Cell Physiol 2003;284:C988-98.
122. Korfhagen TR, Kitzmiller J, Chen G, et al. SAM-pointed domain ETS factor mediates epithelial cell-intrinsic innate immune signaling during airway mucous metaplasia. Proc Natl Acad Sci USA 2012;109:16630-5.
123. Park K-S, Korfhagen TR, Bruno MD, et al. SPDEF regulates goblet cell hyperplasia in the airway epithelium. J Clin Invest 2007;117:978-88.
124. Oettgen P, Finger E, Sun Z, et al. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J Biol Chem 2000;275:1216-25.
125. Chen G, Korfhagen TR, Xu Y, et al. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J Clin Invest 2009;119:2914-24.
126. Bai J, Miao B, Wu X, et al. Enhanced expression of SAM-pointed domain-containing Ets-like factor in chronic rhinosinusitis with nasal polyps. Laryngoscope 2015;125:E97-103.
127. Kreda SM, Seminario-Vidal L, van Heusden CA, et al. Receptor-promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotides. J Physiol 2010;588:2255-67.
128. Seminario-Vidal L, Okada SF, Sesma JL, et al. Rho signaling regulates pannexin 1-mediated ATP release from airway epithelia. J Biol Chem 2011;286:26277-86.
129. Ransford GA, Fregien N, Qiu F, et al. Pannexin 1 contributes to ATP release in airway epithelia. Am J Respir Cell Mol Biol 2009;41:525-34.
130. Bao L, Locovei S, Dahl G. Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett 2004;572:65-8.
131. Locovei S, Wang J, Dahl G. Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett 2006;580:239-44.
132. Lieb T, Frei CW, Frohock JL, et al. Prolonged increase in ciliary beat frequency after short-term purinergic stimulation in human airway epithelial cells. J Physiol 2002;538:633-46.
133. Korngreen A, Priel Z. Purinergic stimulation of rabbit ciliated airway epithelia: control by multiple calcium sources. J Physiol 1996;497 (Pt 1):53-66.
134. Iglesias R, Locovei S, Roque A, et al. P2X7 receptor-Pannexin1 complex: pharmacology and signaling. Am J Physiol Cell Physiol 2008;295:C752-60.
135. Locovei S, Scemes E, Qiu F, et al. Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett 2007;581:483-8.
136. Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 2006;25:5071-82.
137. Yan Z, Khadra A, Li S, et al. Experimental characterization and mathematical modeling of P2X7 receptor channel gating. J Neurosci 2010;30:14213-24.
138. Jiang L-H, Rassendren F, Mackenzie A, et al. N-methyl-D-glucamine and propidium dyes utilize different permeation pathways at rat P2X(7) receptors. Am J Physiol Cell Physiol 2005;289:C1295-302.
139. Alenmyr L, Uller L, Greiff L, et al. TRPV4-mediated calcium influx and ciliary activity in human native airway epithelial cells. Basic Clin Pharmacol Toxicol 2014;114:210-16.
140. Lorenzo IM, Liedtke W, Sanderson MJ, et al. TRPV4 channel participates in receptor-operated calcium entry and ciliary beat frequency regulation in mouse airway epithelial cells. Proc Natl Acad Sci USA 2008; 105:12611-16.
141. Andrade YN, Fernandes J, Vazquez E, et al. TRPV4 channel is involved in the coupling of fluid viscosity changes to epithelial ciliary activity. J Cell Biol 2005;168:869-74.
142. Watanabe H, Vriens J, Prenen J, et al. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 2003;424:434-8.
143. Fernandes J, Lorenzo IM, Andrade YN, et al. IP3 sensitizes TRPV4 channel to the mechano- and osmotransducing messenger 5'-6'-epoxyeicosatrienoic acid. J Gen Physiol 2008;131:i2.
144. Fernandez-Fernandez JM, Andrade YN, Arniges M, et al. Functional coupling of TRPV4 cationic channel and large conductance, calcium-dependent potassium channel in human bronchial epithelial cell lines. Pflugers Arch 2008;457:149-59.
145. Liu X, Bandyopadhyay BC, Bandyopadhyay B, et al. A role for AQP5 in activation of TRPV4 by hypotonicity: concerted involvement of AQP5 and TRPV4 in regulation of cell volume recovery. J Biol Chem 2006;281:15485-95.
146. Taylor-Clark TE, Undem BJ. Sensing pulmonary oxidative stress by lung vagal afferents. Respir Physiol Neurobiol 2011;178:406-13.
147. Grunberg K, Timmers MC, Smits HH, et al. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy 1997;27:36-45.
148. Empey DW, Laitinen LA, Jacobs L, et al. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976;113:131-9.
149. Madison JM, Irwin RS. Pharmacotherapy of chronic cough in adults. Expert Opin Pharmacother 2003;4:1039-48.
150. Myers AC, Kajekar R, Undem BJ. Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am J Physiol Lung Cell Mol Physiol 2002;282: L775-81.
151. Mazzone SB, Mori N, Canning BJ. Synergistic interactions between airway afferent nerve subtypes regulating the cough reflex in guinea-pigs. J Physiol 2005;569:559-73.
152. Lieu TM, Myers AC, Meeker S, et al. TRPV1 induction in airway vagal low-threshold mechanosensory neurons by allergen challenge and neurotrophic factors. Am J Physiol Lung Cell Mol Physiol 2012;302:L941-8.
153. Lieu T, Kollarik M, Myers AC, et al. Neurotrophin and GDNF family ligand receptor expression in vagal sensory nerve subtypes innervating the adult guinea pig respiratory tract. Am J Physiol Lung Cell Mol Physiol 2011;300:L790-8.
154. Hunter DD, Myers AC, Undem BJ. Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons. Am J Respir Crit Care Med 2000;161:1985-90.
155. Neumann S, Doubell TP, Leslie T, et al. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996;384:360-4.
156. Woolf CJ. Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain. Philos Trans R Soc B Biol Sci 1996;351:441-8.
157. Ganju P, O'Bryan JP, Der C, et al. Differential regulation of SHC proteins by nerve growth factor in sensory neurons and PC12 cells. Eur J Neurosci 1998;10:1995-2008.
158. Othumpangat S, Regier M, Piedimonte G. Nerve growth factor modulates human rhinovirus infection in airway epithelial cells by controlling lCAM-1 expression. Am J Physiol Lung Cell Mol Physiol 2012;302:L1057-66.
159. El-Hashim AZ, Jaffal SM, Al-Rashidi FT, et al. Nerve growth factor enhances cough via a central mechanism of action. Pharmacol Res 2013;74:68-77.
160. El-Hashim AZ, Jaffal SM. Nerve growth factor enhances cough and airway obstruction via TrkA receptor- and TRPV1-dependent mechanisms. Thorax 2009;64:791-7.
161. Bonvini SJ, Birrell MA, Grace MS, et al. TRPV4 and activation of airway sensory nerves: the role of ATP. Presented at Pharmacology 2014 Basic pharmacology oral communications (VII). 2014.
162. Aizawa N, Wyndaele J-J, Homma Y, et al. Effects of TRPV4 cation channel activation on the primary bladder afferent activities of the rat. Neurourol Urodyn 2012;31:148-55.
163. Kamei J, Takahashi Y. Involvement of ionotropic purinergic receptors in the histamine-induced enhancement of the cough reflex sensitivity in guinea pigs. Eur J Pharmacol 2006;547:160-4.
164. Basoglu OK, Barnes PJ, Kharitonov SA, et al. Effects of aerosolized adenosine 5'-triphosphate in smokers and patients with Chronic Obstructive Pulmonary Disease. Chest 2015;148:430-5.
165. Basoglu OK, Pelleg A, Essilfie-Quaye S, et al. Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. Chest 2005;128:1905-9.
166. Abdulqawi R, Dockry R, Holt K, et al. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet 2015;385:1198-205.
167. Chiu IM, von Hehn CA, Woolf CJ. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat Neurosci 2012;15:1063-7.
168. Durham PL. Calcitonin gene-related peptide (CGRP) and migraine. Headache 2006;46(Suppl 1):S3-8.
169. Barnes PJ. Neurogenic inflammation in the airways. Respir Physiol 2001;125:145-54.
170. Gentile DA, Skoner DP. Viral rhinitis. CurrAllergyAsthma Rep 2001;1:227-34.
171. Diogenes A, Ferraz CCR, Akopian AN, et al. LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons. J Dent Res 2011;90:759-64.
172. Qi J, Buzas K, Fan H, et al. Painful pathways induced by TLR stimulation of dorsal root ganglion neurons. J Immunol 2011;186:6417-26.
173. Liu T, Xu Z-Z, Park C-K, et al. Toll-like receptor 7 mediates pruritus. Nat Neurosci 2010;13:1460-2.
174. Park C-K, Xu Z-Z, Berta T, et al. Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron 2014;82:47-54.
175. Winkler CW, Taylor KG, Peterson KE. Location is everything: let-7b microRNA and TLR7 signaling results in a painful TRP. Sci Signal 2014;7:14.
176. Souslova V, Cesare P, Ding Y, et al. Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature 2000;407:1015-17.
177. Lakshmi S, Joshi PG. Co-activation of P2Y2 receptor and TRPV channel by ATP: implications for ATP induced pain. Cell Mol Neurobiol 2005;25:819-32.
178. Binshtok AM, Wang H, Zimmermann K, et al. Nociceptors are interleukin-1beta sensors. J Neurosci 2008;28:14062-73.
179. Nicol GD, Lopshire JC, Pafford CM. Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons. J Neurosci 1997;17:975-82.
180. Nagata K, Duggan A, Kumar G, et al. Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing. J Neurosci 2005;25:4052-61.
181. Corey DP, Garcia-Anoveros J, Holt JR, et al. TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells. Nature 2004;432:723-30.
182. Kwan KY, Allchorne AJ, Vollrath MA, et al. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron 2006;50:277-89.
183. Tritsch NX, Yi E, Gale JE, etal. The origin of spontaneous activity in the developing auditory system. Nature 2007;450:50-5.
184. Araki L. TRP channels in urinary bladder mechanosensation. In: Islam S, ed. Transient receptor potential channels: advances in experimental medicine and biology, 2011:861-79.
185. Andersson K-E, Gratzke C, Hedlund P. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder. BJU Int 2010;106:1114-27.
186. Kaan TKY, Yip PK, Grist J, et al. Endogenous purinergic control of bladder activity via presynaptic P2X3 and P2X2/3 receptors in the spinal cord. J Neurosci 2010;30:4503-7.
187. Laing RJ, Dhaka A. ThermoTRPs and Pain. Neuroscientist 2015. Published Online First: 21 January 2015.
188. Julius D. TRP channels and pain. Annu Rev Cell Dev Biol 2013;29:355-84.
189. Ulmann L, Hatcher JP, Hughes JP, et al. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci 2008;28:11263-8.
190. Chessell IP, Hatcher JP, Bountra C, et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005;114:386-96.
191. McGaraughty S, Wismer CT, Zhu CZ, et al. Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br J Pharmacol 2003;140:1381-8.
192. Cockayne DA, Hamilton SG, Zhu QM, et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000;407:1011-15.
193. Gum RJ, Wakefield B, Jarvis MF. P2X receptor antagonists for pain management: examination of binding and physicochemical properties. Purinergic Signal 2012;8:41-56.
194. Guo A, Vulchanova L, Wang J, et al. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 1999;11:946-58.
195. Abdullah H, Heaney LG, Cosby SL, et al. Rhinovirus upregulates transient receptor potential channels in a human neuronal cell line: implications for respiratory virus-induced cough reflex sensitivity. Thorax 2014;69:46-54.
196. Johnston SL. Overview of virus-induced airway disease. Proc Am Thorac Soc 2005;2:150-6.
197. McGarvey LP, Butler CA, Stokesberry S, et al. Increased expression of bronchial epithelial transient receptor potential vanilloid 1 channels in patients with severe asthma. J Allergy Clin Immunol 2014;133:704-124.
198. Mitchell JE, Campbell AP, New NE, et al. Expression and characterization of the intracellular vanilloid receptor (TRPV1) in bronchi from patients with chronic cough. Exp Lung Res 2005;31:295-306.
199. Groneberg DA, Niimi A, Dinh QT, et al. Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med 2004;170:1276-80.
200. Dicpinigaitis PV, Spinner L, Santhyadka G, et al. Effect of tiotropium on cough reflex sensitivity in acute viral cough. Lung 2008;186:369-74.
201. Pratter MR. Cough and the common cold: ACCP evidence-based clinical practice guidelines. Chest 2006;129:72S-4S.